RxDoctor Payments Data

Maciej Nowakowski, MD

Sleep Medicine · Binghamton, NYNPI 1952396210

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,945 of the $2,736 with a category attached, or 71.1%. 21 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 38.8% of the total.

$2,736in general payments, 2019–2025

Across 77 payments — averaging $35.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$1K
  • Jazz Pharmaceuticals Inc.$556
  • Avadel CNS Pharmaceuticals, LLC$439
  • Itamar Medical Inc$108
  • Harmony Biosciences LLC$100
  • Novo Nordisk$61
  • plus $408 from 15 others

What the payments were for

  • Travel & lodging$62323%
  • Food & beverage$1,94571%
  • Education$1676%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,736 in reported general payments places this provider in the 70th percentile of 81 sleep medicine providers in New York.

See all sleep medicine providers in New York

Medicare billing

Part B allowed, 2024
$65,910
Medicare patients
552
Services billed
892

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XywavSodium,calcium,mag,pot Oxybate12$240,423
SunosiSolriamfetol Hcl24$20,047
NeuproRotigotine12$16,471
Modafinil52$2,087
Gabapentin141$1,123
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine24$978
Doxepin Hcl29$931
Ropinirole Hcl54$643
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine12$605
Temazepam21$470
Trazodone Hcl51$458
Armodafinil12$396
Hydroxyzine Hcl14$218
Clonazepam20$91
Lorazepam15$85

Paid to pharmacies, not to this prescriber.

Other sleep medicine in Binghamton

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →